|
PRR12 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.046000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.393200E-01 |
| Normal-vs-Stage2 |
9.494000E-01 |
| Normal-vs-Stage3 |
1.619630E-01 |
| Normal-vs-Stage4 |
5.713400E-01 |
| Stage1-vs-Stage2 |
4.093000E-01 |
| Stage1-vs-Stage3 |
4.135400E-01 |
| Stage1-vs-Stage4 |
8.155000E-01 |
| Stage2-vs-Stage3 |
2.063400E-01 |
| Stage2-vs-Stage4 |
6.325000E-01 |
| Stage3-vs-Stage4 |
4.326600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.683800E-01 |
| Normal-vs-AfricanAmerican |
2.926200E-01 |
| Normal-vs-Asian |
5.485400E-01 |
| Caucasian-vs-AfricanAmerican |
3.623700E-02 |
| Caucasian-vs-Asian |
7.854000E-01 |
| AfricanAmerican-vs-Asian |
1.116750E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.980600E-01 |
| Normal-vs-Female |
2.189000E-01 |
| Male-vs-Female |
2.797600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.666000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.648600E-01 |
| Normal-vs-Age(61-80Yrs) |
4.740800E-01 |
| Normal-vs-Age(81-100Yrs) |
9.452400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.054600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.540000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.940800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.225800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.276000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.761200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.40089999999205E-05 |
| Classical-VS-Follicular |
6.340400E-02 |
| Classical-VS-Other |
3.215600E-01 |
| Classical-VS-Normal |
8.485200E-01 |
| Tall-VS-Follicular |
6.236400E-02 |
| Tall-VS-Other |
4.960800E-01 |
| Tall-VS-Normal |
3.240200E-03 |
| Follicular-VS-Other |
7.671200E-01 |
| Follicular-VS-Normal |
1.914030E-01 |
| Other-VS-Normal |
3.503200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.334800E-01 |
| Normal-vs-N1 |
1.156440E-01 |
| N0-vs-N1 |
2.075200E-01 |
|
|
